Poulton Jeffrey V.

EDGAR CIK 0001782962

Alnylam Pharmaceuticals, Inc. - ALNY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
5
($3.74) M
-10,008 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/02/2025
10/03/2025
Sell
-3,821 @ $452.05
 ($1,727,284) 54,052 (-6.60%) Direct
08/18/2025
08/19/2025
Sell
-2,274 @ $453.27
 ($1,030,727) 50,121 (-4.34%) Direct
03/03/2025
03/05/2025
Sell
-1,264 @ $243.78
 ($308,141) 47,751 (-2.58%) Direct
02/14/2025
02/18/2025
Sell
-967 @ $255.17
 ($246,750) 32,786 (-2.86%) Direct
11/26/2024
11/27/2024
Sell
-1,682 @ $250.98
 ($422,144) 30,644 (-5.20%) Direct